Market revenue in 2023 | USD 955.6 million |
Market revenue in 2030 | USD 1,308.4 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.51% in 2023. Horizon Databook has segmented the Italy in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare system in Italy is well-established, which is contributing to the growth of the IVF market in the country. The rise in demand for IVF in the country is mainly due to married couples above 35 years of age. Stable economic conditions and fairly good reimbursement policies are among the factors boosting the demand for IVF in the country.
In Italy, as well as in many other countries, infertility affects approximately 20% of the population. Many women in Italy undergo assisted reproductive treatment when they are over 37 years old, reflecting the increasing trend of delayed parenthood. In fact, 35.2% of the total number of candidates for ART in Italy are older than 40 years.
Furthermore, in October 2022, Future Life, a prominent Pan-European provider of IVF and related genetics services, expanded its presence into Spain and Italy through a strategic partnership with Institute Marques. Institute Marques, based in Barcelona, is recognized as one of the most innovative IVF providers in Europe.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Italy in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account